Name: Inhibikase Therapeutics Inc (IKT) Dividend History
Creator: GuruFocus
Keywords: IKT dividend, Inhibikase Therapeutics Inc dividend history, IKT ex-dividend date, IKT yield

Inhibikase Therapeutics Inc (IKT) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -215.2%. View its historical dividend record below and compare with dividend-paying peers.

Inhibikase Therapeutics Inc does not pay dividend.

If you're interested in stocks that pay dividends, check out our high yield dividend screener to find our best dividend stocks, or explore our list of top dividend stocks below.

Top dividend stocks to research:

AMCR Amcor PLC Dividend yield : 5.96%

CLX Clorox Co Dividend yield : 5.18%

O Realty Income Corp Dividend yield : 4.98%

KMB Kimberly-Clark Corp Dividend yield : 4.70%

HRL Hormel Foods Corp Dividend yield : 4.65%

TROW T. Rowe Price Group Inc Dividend yield : 4.37%

PEP PepsiCo Inc Dividend yield : 4.26%

WBA Walgreens Boots Alliance Inc Dividend yield : 4.17%

BEN Franklin Resources Inc Dividend yield : 4.01%

PBCT People's United Financial Inc Dividend yield : 3.76%

SWK Stanley Black & Decker Inc Dividend yield : 3.76%

CVX Chevron Corp Dividend yield : 3.65%

MKC McCormick & Co Inc Dividend yield : 3.61%

FRT Federal Realty Investment Trust Dividend yield : 3.60%

GPC Genuine Parts Co Dividend yield : 3.51%

ESS Essex Property Trust Inc Dividend yield : 3.51%

BF.B Brown-Forman Corp Dividend yield : 3.50%

MDT Medtronic PLC Dividend yield : 3.46%

TGT Target Corp Dividend yield : 3.29%

IBM International Business Machines Corp Dividend yield : 3.20%

Also check out

High Yield Dividend Stocks in Gurus' Portfolio

Top dividend stocks of Warren Buffett

Top dividend stocks of George Soros

All-in-one Screener

Screen For High Dividend Stocks

Frequently Asked Questions: IKT Dividend

Does Inhibikase Therapeutics Inc (IKT) pay a dividend?

Inhibikase Therapeutics Inc (IKT) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Inhibikase Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Inhibikase Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -215.2% over the past 3 years.

What are dividend-paying alternatives to Inhibikase Therapeutics Inc?

For dividend-paying alternatives in Inhibikase Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.